A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass

PHASE2TerminatedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

June 30, 2006

Conditions
Heart DiseasesPostoperative Complications
Interventions
DRUG

INO-1001

Trial Locations (13)

3065

St. Vincent's Hospital, Melbourne

6000

Royal Perth Hospital, Perth

19104

University of Pennsylvania, Philadelphia

58100

Wolfson Medical Centre, Holon

73152

University of Oklahoma, Oklahoma City

77030

Methodist Hospital, Houston

110029

Escorts Heart Institute and Research Centre, New Delhi

02215

Beth Israel Deaconess Medical Center, Boston

Unknown

Rapid City Regional Hospital, Rapid City

Sydney

Ashford Cardiac Clinic / Adelaide Cardiac, Adelaide

Care Hospital, Hyderabad

Jerusalem

All Listed Sponsors
lead

Inotek Pharmaceuticals Corporation

INDUSTRY

NCT00271167 - A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass | Biotech Hunter | Biotech Hunter